RV3MAG-26K

MILLIPLEX^® Rat Vascular Injury Magnetic Bead Panel 3 - Toxicity Multiplex Assay

The analytes available for this multiplex kit are: α-1-Acid Glycoprotein (AGP), α-2-Macroglobulin (A2M), Haptoglobin.

• UNSPSC-Code: 12161503
• eCl@ss: 32161000
• NACRES: NA.84

Eigenschaften

• Qualitätsniveau: 200
• Speziesreaktivität: rat
• Hersteller/Markenname: Milliplex^®
• assay range: accuracy: 91-102%; standard curve range: 0.1-100 ng/mL; (α-2-Macroglobulin (A2M)); standard curve range: 0.3-200 ng/mL; (Haptoglobin); standard curve range: 0.4-300 ng/mL; (α-1-Acid Glycoprotein (AGP))
• Methode(n): multiplexing: suitable
• Nachweisverfahren: fluorometric (Luminex xMAP)
• Versandbedingung: wet ice

Beschreibung

Allgemeine Beschreibung

Vascular injury is important to address during the preclinical safety study of drugs. A lack of well-defined mechanisms of drug-induced vascular injury (DIVI) in animals, and the absence of specific, qualified biomarkers have become significant barriers in the development of new therapeutic treatments. In the past, hemodynamics, such as heart rate and mean arterial blood pressure, were used to measure DIVI risks but these only targeted single biomarkers. Today, some of the known vascular injury mechanisms are related to vascular wall shear and/or circumferential “hoop” stress, drug/chemical toxicity, and immunological mediation. With these known biomechanics, primary targets (smooth muscle, endothelial and immune-mediated cells) yield a number of promising candidate biomarkers for DIVI study. We provide valuable research assays to investigate multiple biomarkers of vascular injury in rat serum and plasma samples using the Luminex^® xMAP^® instrument platform.

The MILLIPLEX^® Rat Vascular Injury Bead Panel 3 contains all the components necessary to measure the following four biomarkers in any combination using Luminex^® xMAP^® technology: α-1-Acid Glycoprotein (AGP), α-2-Macroglobulin (A2M), Haptoglobin. The kit uses a 96-well format, contains a lyophilized standard cocktail, two quality controls and can measure up to 38 serum or plasma samples in duplicate.

Panel Type: Toxicity

Spezifität

Cross Reactivty
There was no or negligible cross-reactivity between the antibodies for an analyte and any of the other analytes within a panel.

Anwendung

• Analytes: α-1-Acid Glycoprotein (AGP), α-2-Macroglobulin (A2M), Haptoglobin
• Recommended Sample type: serum and plasma
• Recommended Sample dilution: 1:40,000
• Assay Run Time: Overnight
• Research Category: Toxicity

Leistungsmerkmale und Vorteile

Design your multiplex kit by choosing available analytes within this panel.

Verpackung

Everything you need in a single kit.

Lagerung und Haltbarkeit

Recommended storage for kit components is 2 - 8°C.

Sonstige Hinweise

Please contact Technical Service for linearity of dilution.

Please note: Sample Type must be selected when configuring this kit.

Sensitivity: See kit protocol for individual analytes sensitivities.

Rechtliche Hinweise

Luminex is a registered trademark of Luminex Corp

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

xMAP is a registered trademark of Luminex Corp

Haftungsausschluss

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Sicherheitshinweise

• Piktogramme: GHS06,GHS08,GHS05,GHS09
• Signalwort: Danger
• H-Sätze: H302 + H332,H311,H317,H318,H373,H411
• P-Sätze: P273 - P280 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338 - P314
• Gefahreneinstufungen: Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
• Zielorgane: Respiratory Tract
• Lagerklassenschlüssel: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects